AVROBIO, Inc. (AVRO) Financials

AVRO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 101.1 million 6.4 million
2023-09-30 110.5 million 7.7 million
2023-06-30 133.8 million 11.8 million
2023-03-31 83.0 million 30.0 million

AVRO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -8.0 million 607000
2023-09-30 -20.2 million 2.2 million
2023-06-30 -14.7 million 1.5 million
2023-03-31 -20.3 million 2.5 million

AVRO Net Income

No data available :(

AVRO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 98.3 million - 878000
2023-09-30 105.8 million - 1.8 million
2023-06-30 124.7 million - 2.4 million
2023-03-31 72.3 million 15.4 million 3.0 million

AVRO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 44.7 million
2023-09-30 44.5 million
2023-06-30 44.3 million
2023-03-31 44.0 million

AVRO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.4 million 5.2 million -
2023-09-30 - 14.8 million 6.3 million -
2023-06-30 - 11.1 million 4.6 million -
2023-03-31 8000 17.3 million 7.9 million -

AVRO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 - -
2023-06-30 - 879000
2023-03-31 - 920000

AVRO

Price: $1.22

52 week price:
0.57
1.70

Earnings Per Share: 0.27 USD

P/E Ratio: -13.20

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 362600

Market Capitalization: 58.8 million

Links: